JP2010090127A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010090127A5 JP2010090127A5 JP2009255878A JP2009255878A JP2010090127A5 JP 2010090127 A5 JP2010090127 A5 JP 2010090127A5 JP 2009255878 A JP2009255878 A JP 2009255878A JP 2009255878 A JP2009255878 A JP 2009255878A JP 2010090127 A5 JP2010090127 A5 JP 2010090127A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- antigenic determinant
- rankl
- virus
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000427 antigen Substances 0.000 claims 4
- 230000000890 antigenic effect Effects 0.000 claims 4
- 102000036639 antigens Human genes 0.000 claims 4
- 108091007433 antigens Proteins 0.000 claims 4
- 108010025832 RANK Ligand Proteins 0.000 claims 3
- 102000014128 RANK Ligand Human genes 0.000 claims 2
- 239000002245 particle Substances 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33104501P | 2001-11-07 | 2001-11-07 | |
| US10/050,902 US7264810B2 (en) | 2001-01-19 | 2002-01-18 | Molecular antigen array |
| US39663502P | 2002-07-19 | 2002-07-19 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003541333A Division JP4658475B2 (ja) | 2001-11-07 | 2002-11-07 | 骨疾患治療用の抗原アレイ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010090127A JP2010090127A (ja) | 2010-04-22 |
| JP2010090127A5 true JP2010090127A5 (enExample) | 2011-02-17 |
Family
ID=31721335
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003541333A Expired - Fee Related JP4658475B2 (ja) | 2001-11-07 | 2002-11-07 | 骨疾患治療用の抗原アレイ |
| JP2009255878A Pending JP2010090127A (ja) | 2001-11-07 | 2009-11-09 | 骨疾患治療用の抗原アレイ |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003541333A Expired - Fee Related JP4658475B2 (ja) | 2001-11-07 | 2002-11-07 | 骨疾患治療用の抗原アレイ |
Country Status (3)
| Country | Link |
|---|---|
| JP (2) | JP4658475B2 (enExample) |
| MX (1) | MXPA04003900A (enExample) |
| RU (1) | RU2322258C2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20080047564A (ko) * | 2005-09-28 | 2008-05-29 | 사이토스 바이오테크놀로지 아게 | 인터루킨-1 컨쥬게이트 및 그의 용도 |
| JP6034285B2 (ja) * | 2010-05-28 | 2016-11-30 | ゾエティス・ベルジャム・エス・アー | 抗原および免疫調節ワクチンおよびコレステロール、ならびにその使用 |
| JP6409528B2 (ja) * | 2014-11-27 | 2018-10-24 | Jnc株式会社 | アミノ基を含むイオン交換基とブチル基を含む疎水性基とを有する多孔性セルロース粒子及びそれを含むクロマトグラフィー担体ならびにｂ型肝炎ウィルスのウィルス様粒子の精製方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9114003D0 (en) * | 1991-06-28 | 1991-08-14 | Mastico Robert A | Chimaeric protein |
| GB9213601D0 (en) * | 1992-06-26 | 1992-08-12 | Mastico Robert A | Protein based delivery system |
| AU770802B2 (en) * | 1998-10-21 | 2004-03-04 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Virus-like particles for the induction of autoantibodies |
-
2002
- 2002-11-07 JP JP2003541333A patent/JP4658475B2/ja not_active Expired - Fee Related
- 2002-11-07 MX MXPA04003900A patent/MXPA04003900A/es active IP Right Grant
- 2002-11-07 RU RU2004117075/15A patent/RU2322258C2/ru not_active IP Right Cessation
-
2009
- 2009-11-09 JP JP2009255878A patent/JP2010090127A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012523121A5 (enExample) | ||
| JP2012507294A5 (enExample) | ||
| JP2010503975A5 (enExample) | ||
| JP2018531290A5 (enExample) | ||
| JP2013510581A5 (enExample) | ||
| WO2010010466A3 (en) | Neutralizing anti-influenza a virus antibodies and uses thereof | |
| JP2011124545A5 (enExample) | ||
| JP2013511813A5 (enExample) | ||
| JP2010143932A5 (enExample) | ||
| JP2008266364A5 (enExample) | ||
| JP2014522928A5 (enExample) | ||
| JP2015164127A5 (enExample) | ||
| JP2011508438A5 (enExample) | ||
| JP2010521616A5 (enExample) | ||
| JP2011136981A5 (enExample) | ||
| JP2012065100A5 (enExample) | ||
| JP2012042477A5 (enExample) | ||
| JP2010538767A5 (enExample) | ||
| JP2010262826A5 (enExample) | ||
| WO2009009215A3 (en) | Enhancement of glycoprotein incorporation into virus-like particles | |
| JP2013500200A5 (enExample) | ||
| JP2013504386A5 (enExample) | ||
| JP2014028813A5 (enExample) | ||
| ZA200902443B (en) | Alphavirus replicon particles matched to protein antigens as immunological adjuvants | |
| JP2013540702A5 (enExample) |